Detection of tetrahydrobiopterin by LC-MS/MS in plasma from multiple species

Bioanalysis

Volumn 1, Issue 5, 2009, Pages 895-903

  Zhao, Yuwen ^a   Cao, Jerry ^a   Chen, Yuan Shek ^a   Zhu, Yongdong ^a   Patrick, Colin ^a   Chien, Benjamin ^a   Cheng, Alphonsus ^b   Foehr, Erik D ^b  

^a Quest Pharmaceutical Services   (United States)

^b BIOMARIN PHARMACEUTICAL INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,6,7,8-TETRAHYDROBIOPTERIN; BIOPTERIN; DRUG DERIVATIVE; TETRAHYDROBIOPTERIN;

ANIMAL; ARTICLE; BLOOD; C57BL MOUSE; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; METHODOLOGY; MOUSE; PHENYLKETONURIA; REGRESSION ANALYSIS; REPRODUCIBILITY; TANDEM MASS SPECTROMETRY; VALIDATION STUDY;

ANIMALS; BIOPTERIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; LEAST-SQUARES ANALYSIS; MICE; MICE, INBRED C57BL; PHENYLKETONURIAS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 77649095645     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.09.77     Document Type: Article

References (16)

1. Niederwieser A, Curtius HC, Wang M, Leupold D. Atypical phenylketonuria with defective biopterin metabolism. Monotherapy with tetrahydrobiopterin or sepiapterin, screening, and study of biosynthesis in man. Eur. J. Pediatr. 138, 110-112 (1982).
2. Blau N, Thony B, Cotton RGH, Hyland K. Disorders of tetrahydrobiopterin and related biogenic amines. In: The Metabolic and Molecular Basis of Inherited Disease (8th Edition). McGraw-Hill, NY, USA, 1725-1776 (2001).
3. Landmesser U, Dikalov S, Price R et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J. Clin. Invest. 111, 1201-1209 (2003).
4. Moens AL, Kass DA. Therapeutic potential of tetrahydrobiopterin for treating vascular and cardiac disease. J. Cardiovas. Pharmacol. 50, 238-246 (2007).
5. Shintaku H, Fujioka H, Sawada Y, Asada M, Yamano T. Plasma biopterin levels and tetrahydrobiopterin responsiveness. Molec. Gen. Metabol. 86 (Suppl. 1), S104-S106 (2005).
6. Thony B, Auerbach G, Blau N. Tetrahydrobiopterin biosynthesis, regeneration, and functions. Biochem. J. 347, 1-16 (2000).
7. Fukushima T, Nixon JC. Analysis of reduced forms of biopterin in biological tissues and fuids. Anal. Biochem. 102, 176-188 (1980).
8. Stea B, Halpern RM, Halpern BC, Smith RA. Quantitative determination of pterins in biological fuids by high performance liquid chromatography. J. Chromatogr. 188, 363-375 (1980).
9. Woolf JH, Nichol CA, Duch DS. Determination of biopterin and other pterins in tissues and body fuids by high-performance liquid chromatography. J. Chromatogr. 274, 398-402 (1983).
10. Tani Y, and Ohno T Analysis of 6R-and 6S-tetrahydrobiopterin and other pterins by reversed-phase ion-pair liquid-chromatography with fuorimetric detection by post column sodium nitrite oxidation. J. Chromatogr. 617, 249-255 (1993).
11. Feillet F, Clarke L, Meli C et al. Saproterin Research Group. Pharmacokinetics of sapropterin in patients with phenylketonuria. Clin. Pharmacokinet. 47, 817-825 (2008).
12. Trefz FK, Burton BK, Longo N et al. Effcacy of sapropterin dihydrochloride in increasing phenylalanine tolerance in children with phenylketonuria: a Phase III, randomized, double-blind, placebo controlled study. J. Pediatr. 154(5), 700-707 (2009).
13. Vasques-Vivar J, Kalyanaraman B, Martasek P et al. Superoxide generation by endothelial nitric oxide synthase: the infuence of cofactors. Proc. Natl Acad. Sci. USA 9, 9220-9225 (1998).
14. Mitchell BM, Webb C. Glucocorticoid-induced hypertension and tetrahyrobiopterin (BH4), a common cofactor for the production of vasoactive molecules. Curr. Hypertens. Rev. 1, 1-6 (2005).
15. Fiege B, Ballhausen D, Kierat L et al. Plasma tetrahydrobiopterin and its pharmacokinetics following oral administration. Mol. Genet. Metab. 81, 45-51 (2004).
16. Gramer G, Garbade SF, Blau N, Lindner M. Pharmacokinetics of tetrahydrobiopterin following oral loadings with three single dosages in patients with phenylketonuria. J. Inherit. Metab. Dis. 32, 52-57 (2009).